VanEck Pharmaceutical ETF Rating $82.01 +1.73 (+2.15%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$81.44 -0.57 (-0.70%) As of 04/11/2025 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.75Holdings in PPH have an aggregate rating of Moderate Buy based on 273 analyst ratings issued in the past year covering 23 companies (94.3% of the portfolio).PPH Aggregate Price Target$82.01High Prediction$82.01Average Prediction$82.01Low Prediction$82.01Holdings in PPH have an aggregate price target of $82.01 and a range of $82.01 to $82.01 covering 23 companies (94.3% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.96%LLYEli Lilly and Company$731.62+1.5%4.9699 of 5 stars2.89$1,017.67 39.1%19Analyst Upgrade6.62%ABBVAbbVie$174.90+0.4%4.8413 of 5 stars2.88$210.71 20.5%26Analyst Forecast6.34%JNJJohnson & Johnson$151.62+2.0%4.5637 of 5 stars2.61$171.67 13.2%18Upcoming EarningsAnalyst Upgrade5.05%CORCencora$284.46+1.9%4.1825 of 5 stars2.80$284.20 -0.1%10Analyst ForecastPositive News4.97%MCKMcKesson$690.43+1.6%4.3279 of 5 stars2.88$668.50 -3.2%16Analyst ForecastNews CoveragePositive News4.87%AZNAstraZeneca$66.29+2.2%3.4459 of 5 stars3.10$89.75 35.4%10Analyst Revision4.77%SNYSanofi$51.50+3.7%3.2295 of 5 stars3.00$62.50 21.4%5Positive News4.73%MRKMerck & Co., Inc.$79.14+2.1%5 of 5 stars2.64$115.50 45.9%224.65%NVONovo Nordisk A/S$64.76+5.8%4.4584 of 5 stars2.80$145.25 124.3%10Gap Up4.64%ZTSZoetis$149.40+1.6%4.4821 of 5 stars3.08$215.90 44.5%12Positive NewsGap Down4.61%TAKTakeda Pharmaceutical$13.90+0.2%2.2352 of 5 stars3.0014.58%HLNHaleon$10.05+4.3%1.9774 of 5 stars2.38$10.95 9.0%8News CoveragePositive NewsGap UpHigh Trading Volume4.57%BMYBristol-Myers Squibb$50.68+0.4%4.6997 of 5 stars2.32$57.67 13.8%19Analyst ForecastNews CoveragePositive News4.44%GSKGSK$34.58+2.9%3.2562 of 5 stars2.60$43.25 25.1%104.41%PFEPfizer$21.89+1.4%4.9934 of 5 stars2.59$31.07 42.0%17Analyst Forecast4.26%TEVATeva Pharmaceutical Industries$13.42+4.7%2.2058 of 5 stars2.86$23.43 74.5%72.33%VTRSViatris$7.54+3.9%2.2801 of 5 stars1.75$10.50 39.3%4News Coverage1.98%JAZZJazz Pharmaceuticals$100.50-1.5%4.7826 of 5 stars2.93$187.71 86.8%14Analyst ForecastNews CoveragePositive NewsGap DownHigh Trading Volume1.08%ELANElanco Animal Health$8.64-0.8%3.9844 of 5 stars2.43$15.17 75.5%7News CoverageGap Down1.05%AXSMAxsome Therapeutics$98.06+2.5%4.4961 of 5 stars3.00$169.80 73.2%16Analyst Revision0.93%OGNOrganon & Co.$11.17-2.3%4.5806 of 5 stars2.43$20.60 84.5%7Analyst ForecastOptions VolumeNews Coverage0.91%PRGOPerrigo$24.59+1.0%4.9207 of 5 stars2.25$33.00 34.2%4News CoveragePositive News0.58%PDCOPatterson Companies$30.91-0.1%3.4038 of 5 stars2.09$26.57 -14.0%11News CoverageHigh Trading Volume This page (NASDAQ:PPH) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe rotation into gold miners is on.They’re deeply undervalued gold developers with massive in-the-ground, proven resources - and now, fast-track ...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PPH Stock Free PPH Stock Alerts